Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Athira Pharma, Inc. | President and CEO, Director | Restricted Stock Units | 108K | $125K | $0.56 | Jun 30, 2025 | Direct |
Athira Pharma, Inc. | President and CEO, Director | Common Stock | 326K | $95.6K | $0.29 | Jul 1, 2025 | Direct |
Athira Pharma, Inc. | President and CEO, Director | Common Stock | 6.56K | $1.64K | $0.25 | Jun 30, 2025 | By Irrevocable Trust of OSL |
Athira Pharma, Inc. | President and CEO, Director | Common Stock | 6.56K | $1.64K | $0.25 | Jun 30, 2025 | By Irrevocable Trust of SWL |
Athira Pharma, Inc. | President and CEO, Director | Common Stock | 6.56K | $1.64K | $0.25 | Jun 30, 2025 | By Irrevocable Trust of WGL |
Athira Pharma, Inc. | President and CEO, Director | Stock Option (Right to Buy) | 334K | Mar 3, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATHA | Athira Pharma, Inc. | Jun 30, 2025 | 3 | -$7.37K | 4 | Jul 2, 2025 | President and CEO, Director |
ATHA | Athira Pharma, Inc. | Mar 3, 2025 | 2 | $0 | 4 | Mar 4, 2025 | President and CEO, Director |
ATHA | Athira Pharma, Inc. | Dec 31, 2024 | 3 | -$14.1K | 4 | Jan 3, 2025 | President and CEO, Director |
ATHA | Athira Pharma, Inc. | Oct 3, 2024 | 1 | $0 | 4/A | Oct 3, 2024 | President and CEO, Director |
ATHA | Athira Pharma, Inc. | Sep 3, 2024 | 2 | -$2.85K | 4 | Sep 5, 2024 | President and CEO, Director |
ATHA | Athira Pharma, Inc. | Feb 15, 2024 | 1 | $0 | 4 | Feb 16, 2024 | CEO, Director |
ATHA | Athira Pharma, Inc. | Jan 4, 2024 | 2 | -$14K | 4/A | Feb 16, 2024 | CEO, Director |
ATHA | Athira Pharma, Inc. | Jan 4, 2024 | 2 | -$14K | 4 | Jan 8, 2024 | Chief Executive Officer, Director |
ATHA | Athira Pharma, Inc. | Jan 27, 2023 | 2 | $1.81K | 4 | Jan 31, 2023 | Chief Executive Officer, Director |
ATHA | Athira Pharma, Inc. | Jun 22, 2022 | 3 | -$16.1K | 4 | Jun 24, 2022 | Chief Executive Officer, Director |
ATHA | Athira Pharma, Inc. | Jan 27, 2022 | 2 | $11.1K | 4 | Jan 31, 2022 | Chief Executive Officer, Director |
ATHA | Athira Pharma, Inc. | Aug 17, 2021 | 3 | $80.6K | 4 | Aug 19, 2021 | Chief Operating Officer |